EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chip-Integrated Optical Modulation Biosensing with Microfluidic Background Reduction for High-Sensitivity Fluorescence Immunoassays

Shmuel Burg, Meir Cohen, Reut Ashkenazy, Sophie Terenteva, Yaniv Lustig, Viki Indenbaum, Ravit Koren, Tran Mai Hoa, Tong Thi Kim Tuyen, Ma Thi Huyen, Nguyen Minh Hoan, Le Thi Hoi und 3 weitere

Biosensors · 02.11.2026 · 16 (11) · 623

DOI: 10.3390/bios16110623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, online erschienen am 02.11.2026. Verfasst von Shmuel Burg und 14 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israeli Ministry of Science and Technology, Israel Innovation Authority.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microfluidic fluorescence immunoassays enable sensitive biomarker detection, but performance is limited by inefficient capture on planar surfaces and background fluorescence from unbound labels. Here, we present chip-based optical modulation biosensing (Chip-OMB), combining three-dimensional magnetic bead-based target capture, bead immobilization, internal fluid flushing, and modulated optical background subtraction. Magnetic beads are concentrated and immobilized in the chamber, while controlled on-chip flushing displaces unbound fluorescent labels without requiring user-performed washing after chip loading. Alternating optical interrogation of the bead cluster and surrounding solution enables background subtraction. Using fluorescently labeled magnetic beads, Chip-OMB achieved limits of detection of 0.1 pM in buffer and 22 pM in undiluted plasma, corresponding to 580-fold and 22-fold lower equivalent fluorophore-concentration limits of detection, respectively, than conventional steady-state bulk fluorescence measurements using a plate reader. Measurements correlated with the laboratory optical modulation biosensing system (R2 = 0.98). In an anti-dengue virus serotype 2 (DENV-2) nonstructural protein 1 (NS1) immunoglobulin G (IgG) immunoassay, Chip-OMB achieved a 3 ng/mL limit of detection with a ~4-log dynamic range. Among 56 sera, 29 DENV-2 cases confirmed by reverse transcription quantitative polymerase chain reaction (RT-qPCR) were Panbio IgG-positive and above the exploratory Chip-OMB cutoff, while all 27 study-defined negative controls were below it.

Förderung

  • Israeli Ministry of Science and Technology
  • Israel Innovation Authority

Zitieren

APA

Burg, S., Cohen, M., Ashkenazy, R., Terenteva, S., Lustig, Y., Indenbaum, V., Koren, R., Hoa, T. M., Tuyen, T. T. K., Huyen, M. T., Hoan, N. M., Hoi, L. T., Trung, N. V., Schwartz, E., & Danielli, A. (2026). Chip-Integrated Optical Modulation Biosensing with Microfluidic Background Reduction for High-Sensitivity Fluorescence Immunoassays. Biosensors, 16(11), 623. https://doi.org/10.3390/bios16110623

Vancouver

Burg S, Cohen M, Ashkenazy R, Terenteva S, Lustig Y, Indenbaum V, et al. Chip-Integrated Optical Modulation Biosensing with Microfluidic Background Reduction for High-Sensitivity Fluorescence Immunoassays. Biosensors. 2026;16(11):623. doi:10.3390/bios16110623

BibTeX
@article{Burg2026,
  author = {Burg, Shmuel and Cohen, Meir and Ashkenazy, Reut and Terenteva, Sophie and Lustig, Yaniv and Indenbaum, Viki and Koren, Ravit and Hoa, Tran Mai and Tuyen, Tong Thi Kim and Huyen, Ma Thi and Hoan, Nguyen Minh and Hoi, Le Thi and Trung, Nguyen Vu and Schwartz, Eli and Danielli, Amos},
  title = {Chip-Integrated Optical Modulation Biosensing with Microfluidic Background Reduction for High-Sensitivity Fluorescence Immunoassays},
  journal = {Biosensors},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {623},
  doi = {10.3390/bios16110623}
}
Kostenlos starten →